Inovio Pharmaceuticals Correlations

INO Stock

USD 4.19 0.18 4.49%

The current 90-days correlation between Inovio Pharmaceuticals and Vaxart Inc is 0.24 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inovio Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inovio Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Inovio Pharmaceuticals Correlation With Market

Very weak diversification

The correlation between Inovio Pharmaceuticals and DJI is 0.46 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Inovio Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inovio Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.

Moving together with Inovio Stock

0.82	FDMT	4D Molecular Therapeutics	Pair Corr
0.81	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.84	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.62	INKT	Mink Therapeutics	Pair Corr
0.62	IVVD	Invivyd	Pair Corr
0.82	MREO	Mereo BioPharma Group	Pair Corr
0.89	NKTX	Nkarta Inc Buyout Trend	Pair Corr
0.81	PEPG	PepGen	Pair Corr
0.66	PIRS	Pieris Pharmaceuticals	Pair Corr
0.69	RGNX	Regenxbio	Pair Corr
0.7	ACRV	Acrivon Therapeutics,	Pair Corr
0.91	ADAP	Adaptimmune Therapeutics	Pair Corr
0.81	AFMD	Affimed NV	Pair Corr
0.71	STOK	Stoke Therapeutics	Pair Corr
0.88	BDTX	Black Diamond Therap	Pair Corr
0.7	COLL	Collegium Pharmaceutical	Pair Corr

Moving against Inovio Stock

0.87	BMY	Bristol Myers Squibb Aggressive Push	Pair Corr
0.69	NAMS	NewAmsterdam Pharma	Pair Corr
0.5	MNOV	MediciNova	Pair Corr
0.37	ESLAW	Estrella Immunopharma	Pair Corr
0.37	PHVS	Pharvaris BV	Pair Corr
0.76	AVTE	Aerovate Therapeutics	Pair Corr
0.73	CRVS	Corvus Pharmaceuticals	Pair Corr
0.71	VREX	Varex Imaging Corp	Pair Corr
0.61	SGMO	Sangamo Therapeutics Buyout Trend	Pair Corr
0.54	AGIO	Agios Pharm	Pair Corr
0.39	ABEO	Abeona Therapeutics	Pair Corr

Related Correlations Analysis

	NVAX	VXRT	ENVB	CWBR	OCEA	HEPA	ELEV	AVRO
NVAX		0.79	0.35	-0.47	0.69	0.06	-0.04	-0.9	NVAX
VXRT	0.79		0.74	-0.58	0.84	0.36	0.24	-0.71	VXRT
ENVB	0.35	0.74		-0.45	0.74	0.38	0.4	-0.29	ENVB
CWBR	-0.47	-0.58	-0.45		-0.43	-0.44	-0.38	0.36	CWBR
OCEA	0.69	0.84	0.74	-0.43		0.36	0.23	-0.71	OCEA
HEPA	0.06	0.36	0.38	-0.44	0.36		0.71	-0.14	HEPA
ELEV	-0.04	0.24	0.4	-0.38	0.23	0.71		-0.02	ELEV
AVRO	-0.9	-0.71	-0.29	0.36	-0.71	-0.14	-0.02		AVRO
	NVAX	VXRT	ENVB	CWBR	OCEA	HEPA	ELEV	AVRO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

OCEA	+ 0.84	VXRT
VXRT	+ 0.79	NVAX
ENVB	+ 0.74	VXRT
OCEA	+ 0.74	ENVB
ELEV	+ 0.71	HEPA
OCEA	+ 0.69	NVAX

High negative correlations

AVRO	- 0.9	NVAX
AVRO	- 0.71	OCEA
AVRO	- 0.71	VXRT
CWBR	- 0.58	VXRT
CWBR	- 0.47	NVAX
CWBR	- 0.45	ENVB

Risk-Adjusted Indicators

There is a big difference between Inovio Stock performing well and Inovio Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Inovio Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NVAX	3.80	(0.37)	0.00	(0.33)	0.00	0.00	9.89	(7.08)	38.60
VXRT	2.72	(0.62)	0.00	(0.71)	0.00	0.00	4.88	(5.95)	20.06
ENVB	3.26	(0.64)	0.00	(3.74)	0.00	0.00	6.25	(7.50)	28.33
CWBR	7.34	2.42	0.33	7.94	5.34	(11.19)	5.73	(5.59)	250.97
OCEA	3.57	(0.42)	0.00	(1.00)	0.00	0.00	7.46	(6.93)	28.33
HEPA	3.70	(0.32)	0.00	(0.09)	0.00	0.00	8.06	(8.11)	33.54
ELEV	3.52	(0.50)	0.00	(0.12)	0.00	0.00	5.77	(8.22)	22.21
AVRO	1.77	0.19	0.01	(0.38)	1.89	(2.24)	4.11	(3.17)	14.20

Inovio Pharmaceuticals Corporate Management

Asli Gevgilili	Chief Officer	Profile
Jeffrey Skolnik	Senior Development	Profile
Robert Juba	Senior Management	Profile
E MBA	Senior Assurance	Profile
MBA MA	Senior Development	Profile
Ben Matone	Director Relations	Profile
Laurent Humeau	Chief Scientific Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC